Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Assessing Exercise Capacity After PulseHaler™ Treatment in GOLD II-IV COPD Patients
Not Applicable
- Conditions
- COPD
- First Posted Date
- 2020-01-22
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- Respinova LTD
- Target Recruit Count
- 104
- Registration Number
- NCT04236076
PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients
Not Applicable
Completed
- Conditions
- COPD
- Interventions
- Device: PulsehalerDrug: Nebulizer & Albuterol 0.5ml
- First Posted Date
- 2010-08-24
- Last Posted Date
- 2011-09-23
- Lead Sponsor
- Respinova LTD
- Target Recruit Count
- 15
- Registration Number
- NCT01187589
- Locations
- 🇮🇱
Assaf Harofe Medical Center Nuclear Medicine Institute, Tzrifin, Israel
Assessment of Treatment With PulseHaler on Patients With Chronic Obstructive Pulmonary Disease (COPD)
Not Applicable
Completed
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2010-05-11
- Lead Sponsor
- Respinova LTD
- Target Recruit Count
- 30
- Registration Number
- NCT00821418
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
News
No news found